H Nakano

A novel therapeutic approach combining human plasma‐derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone

Y. Nakatomi, K. Tomokiyo, T. Nakagaki, 2003, Vox sanguinis.

Circulating Matrix Metalloproteinases and Their Inhibitors in Patients with Kawasaki Disease

S Masutani, S. Masutani, H. Senzaki, 2001, Circulation.